Armistice Capital’s Amryt Pharma plc American Depositary Shares AMYT Stock Holding History

Armistice Capital’s Portfolio AMYT Stock Details AMYT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-978,000	Closed	-$7.14M	–	267
2022 Q4	$7.14M	Sell	978,000 -294,000	-23%	-$2.07M	0.12%	87
2022 Q3	$8.8M	Buy	1,272,000 +94,000	+8%	+$701K	0.15%	77
2022 Q2	$8.23K	Buy	1,178,000 +178,000	+18%	+$1.39M	0.14%	86
2022 Q1	$8.27M	Buy	1,000,000 +200,000	+25%	+$1.8M	0.16%	79
2021 Q4	$8.64M	Buy	800,000 +176,000	+28%	+$1.9M	0.14%	98
2021 Q3	$7.52M	Buy	624,000 +288,000	+86%	+$3.25M	0.13%	97
2021 Q2	$4.08M	Buy	336,000 +136,000	+68%	+$1.69M	0.07%	98
2021 Q1	$2.79M	Hold	200,000	–	–	0.06%	96
2020 Q4	$2.83M	Sell	200,000 -106,000	-35%	-$1.38M	0.1%	90
2020 Q3	$3.78M	Buy	+306,000	New	+$3.54M	0.14%	83

Other funds holding AMYT

ACM

Athyrium Capital Management New York $8.69M AUM 34.58% 1-Year Est. Return

HCM

Highbridge Capital Management New York $3.09B AUM 31.19% 1-Year Est. Return

SCM

Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return

MAM

MPM Asset Management Boston, Massachusetts $44.5M AUM 47.28% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

PCM

Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return

UOC

UBS O'Connor Chicago, Illinois $3.38B AUM 63.08% 1-Year Est. Return

TAL

TIG Advisors LLC New York $2.16B AUM 72.99% 1-Year Est. Return

AAM

Alpine Associates Management Palm Beach, Florida $1.7B AUM 97.55% 1-Year Est. Return

RSCM

Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return

Armistice Capital's AMYT Position: Q1 2023 in Review

Armistice Capital sold out of Amryt Pharma plc American Depositary Shares (AMYT) in Q1 2023, closing a stake of 978,000 shares — an estimated $7.14M sold.

Armistice Capital first reported a position in AMYT in Q3 2020 and held it in 10 quarters. The position peaked at $8.8M in Q3 2022. 79 funds tracked by Wall St. Rank hold AMYT as of Q1 2023.

Armistice Capital reported no remaining Amryt Pharma plc American Depositary Shares position as of Q1 2023 after selling out during the quarter.
Armistice Capital sold 978,000 Amryt Pharma plc American Depositary Shares shares in Q1 2023, an estimated $7.14M.
Armistice Capital first reported a position in Amryt Pharma plc American Depositary Shares in Q3 2020 and held it in 10 quarters.
Armistice Capital's Amryt Pharma plc American Depositary Shares position peaked at $8.8M in Q3 2022.
79 funds tracked by Wall St. Rank held Amryt Pharma plc American Depositary Shares as of Q1 2023.

Based on Armistice Capital's 13F filing for Q1 2023, filed 15 May 2023.